Cargando…
Perceptions of Regulatory Decision-Making for New Drugs From the Viewpoints of the Manufacturers in South Korea
Regulatory decisions for new drugs approval present high uncertainty, low reversibility, the avoidance of observable errors, and high political stakes. However, research on the behavior of regulatory agencies is scarce, particularly in the context of more open decision-making processes. We aimed to...
Autores principales: | Son, Kyung-Bok, Park, Sylvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006612/ https://www.ncbi.nlm.nih.gov/pubmed/35433745 http://dx.doi.org/10.3389/fmed.2022.869262 |
Ejemplares similares
-
Perceived impact of the patent linkage system on pharmaceutical market from the viewpoint of the domestic manufacturers in South Korea
por: Choi, Nahye, et al.
Publicado: (2022) -
Is greater generic competition also linked to lower drug prices in South Korea?
por: Son, Kyung-Bok
Publicado: (2020) -
Market Exclusivity of the Originator Drugs in South Korea: A Retrospective Cohort Study
por: Son, Kyung-Bok
Publicado: (2021) -
Bridging Neural and Computational Viewpoints on Perceptual Decision-Making
por: O’Connell, Redmond G., et al.
Publicado: (2018) -
Role of economic evidence in coverage decision-making in South Korea
por: Bae, Eun-Young, et al.
Publicado: (2018)